The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

Corrections

Published Online:https://doi.org/10.1176/ajp.134.5.589-b

The first sentence of the précis of "Low Urinary Dopamine and Prediction of Phenothiazine-Induced Parkinsonism: A Preliminary Report" by Thomas J. Crowley, M.D., Charles O. Rutledge, Ph.D., Margaret M. Hoehn, M.D., Mary Ann Stallings, R.N., M.S., and Seymour Sundell, M.D. (p. 703, June 1976 issue) should have read: "Psychiatric patients who excreted larger amounts of urinary free dopamine before treatment were significantly less likely than patients excreting smaller amounts to develop parkinsonian side effects."

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.